Learn more

UNIV BARI

Overview
  • Total Patents
    75
  • GoodIP Patent Rank
    224,200
About

UNIV BARI has a total of 75 patent applications. Its first patent ever was published in 1997. It filed its patents most often in EPO (European Patent Office), Italy and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CHEMGENEX PHARMACEUTICALS LTD, ANAMAR AB and NIPPON ZOKI PHARMACEUTICAL CO.

Patent filings per year

Chart showing UNIV BARIs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Scilimati Antonio 12
#2 Perrone Maria Grazia 7
#3 Colabufo Nicola Antonio 7
#4 Torsi Luisa 7
#5 Perrone Roberto 7
#6 Berardi Francesco 7
#7 Vitale Paola 6
#8 Scamarcio Gaetano 6
#9 Santandrea Ernesto 5
#10 Schena Francesco Paolo 5

Latest patents

Publication Filing date Title
WO2016046763A1 Selective agonists of beta-adrenergic type 3 receptors (bar3) and use thereof
WO2014115020A1 Heterocycles and their radiolabeled analogs useful as cox-1 selective inhibitors
EP2986286A1 Galloyl benzamide-based compounds as jnk modulators
WO2013076592A1 Method and apparatus for thermal conditioning of olives or other oleaginous fruits combined with a crushing and kneading system of olives or other oleaginous fruits in controlled or modified atmosphere
EP2741792A1 Process for the production by plasma of nanometric thickness coatings allowing controlled release of silver ions of other elements, or of molecules of biomedical interest, from solid products, and products thus coated
WO2013068776A1 Combination of active ingredients for the treatment of acute kidney injury
WO2013065073A1 Organic field -effect transistor sensor
WO2012056282A1 Method and kit for the diagnosis of iga nephropathy
WO2012020295A1 Optical elements having long-lasting hydrophilic and anti-fog properties and method for their preparation
WO2012159674A1 Method of screening for therapeutic compounds useful in detoxifying central nervous system from b-amyloid peptide
WO2012159662A1 New 1-arylpiperazinic ligands of 5-ht7 receptor and use thereof
WO2012159666A1 Novel tetrahydroisoquinoline compounds for use in the diagnosis and treatment of neurodegenerative diseases
EP2568998A1 Use of interferon alpha for the treatment of chronic kidney disease
EP2479533A1 Laser system for ablation monitoring
EP2385563A1 Organic field effect transistors based on multilayers of self-assembled biological systems covered by an organic semiconductor layer and sensor thereof.
EP2182054A1 Process for identification and isolation of mesenchymal cells with marked bone regenerative ability
EP2151238A1 Diazoxide for the treatment of Friedreich's ataxia
EP2166328A1 System for optical fiber strain measure
EP2157211A1 Bioactive metal nanomaterials stabilized by bioactive agents and preparation process
EP2123797A1 Nanomaterials for controlled metal release and process for their production